MUS81 and EME1 constitute a heterodimeric endonuclease that has been implicated in mitotic and meiotic recombination in eukaryotes.
| Inventor | Institute |
|---|---|
| Stephen West | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| Cat. #: | 151291 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Genetics |
| Application: | IF ; ICC ; FACS ; IHC ; IF ; IP ; WB |
| Target: | MUS81 |
| Reactivity: | Human |
| Clone: | MTA30 2G10/3 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | MUS81 and EME1 constitute a heterodimeric endonuclease that has been implicated in mitotic and meiotic recombination in eukaryotes. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | 60-65 kDa |
| Immunogen: | Human MUS81 |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | MUS81 and EME1 constitute a heterodimeric endonuclease that has been implicated in mitotic and meiotic recombination in eukaryotes. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Xu et al. 2019. Sci Adv. 5(10):eaax6366. PMID: 31633027. Panier et al. 2019. Mol Cell. 76(1):27-43.e11. PMID: 31447390. Mason et al. 2019. Nat Commun. 10(1):4410. PMID: 31562309. Xu et al. 2017. Elife. 6:. PMID: 29106372. Moder et al. 2017. Nat Commun. 8(1):1238. PMID: 29089570. Lemaon et al. 2017. Nat Commun. 8(1):860. PMID: 29038425. Li et al. 2017. Mol Med Rep. 16(4):5321-5325. PMID: 28849153. Dungrawala et al. 2017. Mol Cell. 67(3):374-386.e5. PMID: 28735897. Di Marco et al. 2017. Mol Cell. 66(5):658-671.e8. PMID: 28575661. Lv et al. 2017. Tumour Biol. 39(3):1010428317694307. PMID: 28347251. Wyatt et al. 2017. Mol Cell. 65(5):848-860.e11. PMID: 28257701. Meisenberg et al. 2017. Nucleic Acids Res. 45(3):1159-1176. PMID: 28180300. Meisenberg et al. 2017. Nucleic Acids Res. 45(3):1159-1176. PMID: 28180300. Jo et al. 2016. PLoS Genet. 12(12):e1006465. PMID: 27906959. Pepe et al. 2014. Nucleic Acids Res. 42(6):3833-45. PMID: 24371268. CtIP is required to initiate replication-dependent interstrand crosslink repair. Duquette et al. 2012. PLoS Genet. 8(11):e1003050. PMID: 23144634. Svendsen et al. 2009. Cell. 138(1):63-77. PMID: 19596235. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Franchitto et al. 2008. J Cell Biol. 183(2):241-52. PMID: 18852298. Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.